MET amplification as a potential therapeutic target against hepatocellular carcinoma

Hepatology ResearchVolume 51, Issue 11 p. 1093-1094 EDITORIAL MET amplification as a potential therapeutic target against hepatocellular carcinoma Yuji Eso, Corresponding Author Yuji Eso yujieso@kuhp.kyoto-u.ac.jp orcid.org/0000-0003-4426-1491 Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan Correspondence Yuji Eso, Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. Email: yujieso@kuhp.kyoto-u.ac.jpSearch for more papers by this author Yuji Eso, Corresponding Author Yuji Eso yujieso@kuhp.kyoto-u.ac.jp orcid.org/0000-0003-4426-1491 Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan Correspondence Yuji Eso, Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. Email: yujieso@kuhp.kyoto-u.ac.jpSearch for more papers by this author First published: 01 November 2021 https://doi.org/10.1111/hepr.13702Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume51, Issue11November 2021Pages 1093-1094 RelatedInformation